Corbus Pharmaceuticals Historical PE Ratio image   This CRBP PE ratio history page last updated 5/9/2024
Corbus Pharmaceuticals Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2024
5/7/2024
39.77-0.83-3.32NA
Q4 2023
3/12/2024
44.58-1.81-7.24NA
Q3 2023
11/7/2023
4.20-2.27-9.08NA
Q2 2023
8/8/2023
6.44-2.05-8.20NA
Q1 2023
5/9/2023
8.87-4.24-16.96NA
Q4 2022
3/7/2023
2.66-2.61-10.44NA
Q3 2022
11/8/2022
3.84-2.10-8.40NA
Q2 2022
8/9/2022
7.65-2.10-8.40NA
Q1 2022
5/10/2022
7.74-2.40-9.60NA
Q4 2021
3/8/2022
10.20-2.40-9.60NA
Q3 2021
11/12/2021
31.80-0.60-2.40NA
Q2 2021
8/12/2021
37.80-4.50-18.00NA
Q1 2021
5/13/2021
41.70-4.20-16.80NA
Q4 2020
3/15/2021
68.10-3.00-12.00NA
Q3 2020
11/10/2020
36.60-12.90-51.60NA
Q2 2020
8/6/2020
189.90-15.60-62.40NA
Q1 2020
5/11/2020
199.20-12.90-51.60NA
Q4 2019
3/12/2020
114.30-12.30-49.20NA
Q3 2019
11/7/2019
135.30-9.60-38.40NA
Q2 2019
8/8/2019
172.500.903.6047.9
Q1 2019
5/9/2019
208.20-12.90-51.60NA
Q4 2018
3/12/2019
181.80-9.00-36.00NA
Q3 2018
11/8/2018
206.25-7.80-31.20NA
Q2 2018
8/8/2018
139.50-6.30-25.20NA
Q1 2018
5/10/2018
178.50-6.30-25.20NA
Q4 2017
3/12/2018
205.50-6.30-25.20NA
Q3 2017
11/8/2017
204.00-4.20-16.80NA
Q2 2017
8/9/2017
181.50-4.50-18.00NA
Q1 2017
5/9/2017
180.00-4.80-19.20NA
Q4 2016
3/9/2017
277.50-5.40-21.60NA
Q3 2016
11/10/2016
181.50-3.60-14.40NA
Q2 2016
8/15/2016
92.40-3.30-13.20NA
Q1 2016
5/16/2016
70.20-2.40-9.60NA
Q4 2015
3/29/2016
53.70-1.80-7.20NA
Corbus Pharmaceuticals PE History Chart
PeriodPriceGAAPTTMPE
Q1 2024
5/7/2024
39.77-0.83-6.96NA
Q4 2023
3/12/2024
44.58-1.81-10.37NA
Q3 2023
11/7/2023
4.20-2.27-11.17NA
Q2 2023
8/8/2023
6.44-2.05-11.00NA
Q1 2023
5/9/2023
8.87-4.24-11.05NA
Q4 2022
3/7/2023
2.66-2.61-9.21NA
Q3 2022
11/8/2022
3.84-2.10-9.00NA
Q2 2022
8/9/2022
7.65-2.10-7.50NA
Q1 2022
5/10/2022
7.74-2.40-9.90NA
Q4 2021
3/8/2022
10.20-2.40-11.70NA
Q3 2021
11/12/2021
31.80-0.60-12.30NA
Q2 2021
8/12/2021
37.80-4.50-24.60NA
Q1 2021
5/13/2021
41.70-4.20-35.70NA
Q4 2020
3/15/2021
68.10-3.00-44.40NA
Q3 2020
11/10/2020
36.60-12.90-53.70NA
Q2 2020
8/6/2020
189.90-15.60-50.40NA
Q1 2020
5/11/2020
199.20-12.90-33.90NA
Q4 2019
3/12/2020
114.30-12.30-33.90NA
Q3 2019
11/7/2019
135.30-9.60-30.60NA
Q2 2019
8/8/2019
172.500.90-28.80NA
Q1 2019
5/9/2019
208.20-12.90-36.00NA
Q4 2018
3/12/2019
181.80-9.00-29.40NA
Q3 2018
11/8/2018
206.25-7.80-26.70NA
Q2 2018
8/8/2018
139.50-6.30-23.10NA
Q1 2018
5/10/2018
178.50-6.30-21.30NA
Q4 2017
3/12/2018
205.50-6.30-19.80NA
Q3 2017
11/8/2017
204.00-4.20-18.90NA
Q2 2017
8/9/2017
181.50-4.50-18.30NA
Q1 2017
5/9/2017
180.00-4.80-17.10NA
Q4 2016
3/9/2017
277.50-5.40-14.70NA
Q3 2016
11/10/2016
181.50-3.60-11.10NA
Q2 2016
8/15/2016
92.40-3.30NANA
Q1 2016
5/16/2016
70.20-2.40NANA
Q4 2015
3/29/2016
53.70-1.80NANA
Quotes delayed 20 minutes

Email EnvelopeFree CRBP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Corbus Pharmaceuticals (CRBP) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CRBU PE Ratio History
CRDF PE Ratio History
CRGX PE Ratio History
CRIS PE Ratio History
CRL PE Ratio History
CRMD PE Ratio History
CRNX PE Ratio History
CRTX PE Ratio History
CRVL PE Ratio History
CRVO PE Ratio History
How should the CRBP historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Corbus Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CRBP Historical PE Ratio page.

What is the average historical PE for CRBP based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CRBP historical PE ratio using the annualized quarterly earnings method works out to 47.9.

What is the average historical PE for CRBP based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CRBP historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Corbus Pharmaceuticals Historical PE Ratio information for Corbus Pharmaceuticals' stock. The average CRBP historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 47.9. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CRBP historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CRBP historical PE result, against the recent PE: when this page was posted on 5/8/2024, the most recent closing price for CRBP had been 42.39, and the most recent quarterly earnings result, annualized, was 3.6. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent CRBP PE on 5/8/2024 based on annualized quarterly EPS was 11.8. Based on CRBP's history, that recent PE is low relative to the historical average, with the recent PE 75.4% lower than the historical average PE across our data set for Corbus Pharmaceuticals.

For self directed investors doing their due diligence on CRBP or any other given stock, valuation analysis for CRBP can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Corbus Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CRBP. Thanks for visiting, and the next time you need to research CRBP Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: NBTB Average Annual Return, Institutional Holders of SWNM, Top Ten Hedge Funds Holding BSTI.

 

Corbus Pharmaceuticals Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.